Back to results
US 11,440,916 B2Granted
Selective A2A receptor antagonist
AssigneeInxmed (Nanjing) Co., Ltd.
InventorsZaiqi Wang, Lihu Yang
Life of this patent
Estimating the term…
Abstract
The present invention relates to a selective A2A receptor antagonist, and in particular to a selective A2A receptor antagonist of Formula (I), a pharmaceutical composition comprising the antagonist, use of the antagonist in manufacturing a medicament and in treatment of a disease: wherein the groups in Formula (I) are defined as in the specification.
Claims14
A compound of Formula (I), or a stereoisomer or pharmaceutically acceptable salt thereof:
- wherein
- n is 0 or 1,
- m is 1 or 2,
- A is nitrogen or carbon;
- X is each independently —R1COOR2,
- R1 is a direct bond or a C1-4 alkylene,
- R2 is H or a C1-4 alkyl,
- with the proviso that when A is nitrogen, X is not attached to A.
5 more elements
Dependencies are inferred from the claim text.